Stay updated with breaking news from Peter Greenleaf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Rating) (TSE:AUP) had its target price hoisted by Royal Bank of Canada from $11.00 to $13.00 in a research report report published on Tuesday, The Fly reports. Royal Bank of Canada currently has an outperform rating on the biotechnology company’s stock. Separately, StockNews.com assumed coverage on shares of Aurinia Pharmaceuticals […]
Operator: Greetings, and welcome to Aurinia Pharmaceuticals Inc. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Rating) (TSE:AUP) announced its quarterly earnings data on Thursday. The biotechnology company reported ($0.18) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.05, Briefing.com reports. Aurinia Pharmaceuticals had a negative return on equity of 25.44% and a negative net margin of 80.71%. The firm […]
$34.4 million in net revenue for the first quarter of 2023; an increase of 59% over the first quarter of the prior year Increases 2023 revenue guidance range to $135 - $155 million from net product... | May 4, 2023
$34.4 million in net revenue for the first quarter of 2023; an increase of 59% over the first quarter of the prior year Increases 2023 revenue guidance range to $135 $155 million from net product